Clinical Trial Update: Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease [Phase 1, Phase 2]

View source ↗

Summary

This document describes a Phase 1/2 clinical trial evaluating fludarabine for steroid-resistant chronic graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Graft Versus Host Disease | Phase 1, Phase 2 | Status: UNKNOWN